Table 2.
Population at risk (n) | No. events | Multivariate-adjusted HR (95% CI) | P | |
---|---|---|---|---|
Men | ||||
Updated 2005 NCEP ATP III | ||||
(−) | 597 | 82 | 1 (referent) | |
(+) | 196 | 63 | 2.58 (1.85–3.59) | <0.001 |
IFG | ||||
(−) | 401 | 35 | 1 (referent) | |
(+) | 392 | 110 | 3.76 (2.57–5.52) | <0.001 |
Central obesity | ||||
(−) | 667 | 103 | 1 (referent) | |
(+) | 126 | 42 | 2.28 (1.58–3.29) | <0.001 |
Reduced HDL cholesterol | ||||
(−) | 614 | 108 | 1 (referent) | |
(+) | 179 | 37 | 1.32 (0.90–1.95) | 0.16 |
Elevated triglycerides | ||||
(−) | 579 | 84 | 1 (referent) | |
(+) | 214 | 61 | 2.05 (1.46–2.88) | <0.001 |
Elevated blood pressure | ||||
(−) | 338 | 41 | 1 (referent) | |
(+) | 455 | 104 | 2.17 (1.49–3.17) | <0.001 |
Women | ||||
Updated 2005 NCEP APT III | ||||
(−) | 723 | 52 | 1 (referent) | |
(+) | 419 | 89 | 3.69 (2.58–5.27) | <0.001 |
IFG | ||||
(−) | 685 | 47 | 1 (referent) | |
(+) | 457 | 94 | 3.50 (2.45–5.00) | <0.001 |
Central obesity | ||||
(−) | 496 | 39 | 1 (referent) | |
(+) | 646 | 102 | 1.96 (1.35–2.85) | <0.001 |
Reduced HDL cholesterol | ||||
(−) | 631 | 64 | 1 (referent) | |
(+) | 511 | 77 | 1.55 (1.10–2.18) | 0.01 |
Elevated triglycerides | ||||
(−) | 973 | 105 | 1 (referent) | |
(+) | 169 | 36 | 2.28 (1.54–3.37) | <0.001 |
Elevated blood pressure | ||||
(−) | 598 | 51 | 1 (referent) | |
(+) | 544 | 90 | 2.49 (1.74–3.58) | <0.001 |
Data are n or HR (95% CI). IFG, FPG levels of 5.6–6.9 mmol/l; central obesity, waist circumference of ≥90 cm in men and ≥80cm in women; reduced HDL cholesterol, HDL cholesterol levels of <1.03 mmol/l in men and <1.29 mmol/l in women; elevated triglycerides, triglyceride levels of ≥1.68 mmol/l; elevated blood pressure, blood pressure ≥130/85 mmHg and/or current use of antihypertension agents. Multivariate adjustment was made for age, family history of diabetes, total cholesterol, alcohol intake, smoking habits, and regular exercise.